CytoRecovery
PrivateLast Round
Accelerator
Jun 3, 2024
Total Funding Raised
$1.55M
Company Overview
CytoRecovery is a biotechnology company that develops microfluidic technology designed to recover biological cells from samples.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoRecovery Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
CytoRecovery Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 3, 2024 | ||||
| Grant | Feb 9, 2023 | ||||
| Seed | Dec 1, 2022 | ||||
| Convertible Debt | Apr 22, 2019 | ||||
| Pre Seed | Oct 19, 2018 |
CytoRecovery Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Virginia LVG Seed Fund | Seed |
| Common Wealth Angels | Seed, Convertible Debt |
| Virginia Innovation Partnership Corporation | Convertible Debt |
| The Launch Place | Pre Seed, Seed |
| BioTools Innovator | Accelerator |
| Bloomfield Partners | Seed, Convertible Debt |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 177% MoM.
- Jan 5, 2026
Monthly visitors grew 44% MoM.
CytoRecovery Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CytoRecovery's valuation, stock price, and market status.